DBA Sempra
SRE · NYSE
Analyst Consensus
Buy
Analyst Ratings Synthesis
Consensus is Buy across 17 analysts, with a mean price target of $105. The supplied data provide no low or high targets, so the target cluster and dispersion cannot be measured. No named firm or analyst is identified as most or least bullish, and the evidence reports no target revisions during the past week. The substantive disagreement behind the available outlook is therefore not documented. The only current directional research signal is Zacks’s expectation that Sempra’s upcoming earnings could grow and potentially beat estimates, while the stock’s 4.32% weekly decline and FY2025 profit contraction provide countervailing evidence.
Rating Actions
No individual rating actions have been captured for SREyet. Consensus figures above come from Nasdaq's aggregate feed.
